WNT7A and Duchenne muscular dystrophy: For example, Abujarour et al. have shown that DMD iPSC-derived myotubes have the potential to functionally respond to hypertrophy-inducing factors Wnt7a and IGF-1, which are tested as potential treatments for DMD [97].